Hexamer Therapeutics, Inc — Form D
Hexamer Therapeutics, Inc of PULLMAN, WA, a company, filed a Form D exempt-offering notice with the SEC on 2019-12-27. The offering totals $1.1M, of which $470K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-12-27
- Form: D
- Accession: 0001797915-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $470K
- Remaining: $630K
- Investors: 3
- Date of first sale: 2019-11-15
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-356536
Issuer
- Name: Hexamer Therapeutics, Inc
- CIK: 0001797915
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2345 NE HOPKINS CT, PULLMAN, WA, 99163
- Phone: 509-715-9251
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Robert Hale Bogden | Director | Pullman, WA |
| Colin Conrad Collins | Director | Vancouver, A1 |
| Keith David Miller | Director | Moscow, ID |
| Robert Hale Bogden | Executive Officer | Pullman, WA |
| Colin Conrad Collins | Executive Officer | Vancouver, A1 |
| Keith David Miller | Executive Officer | Moscow, ID |
| Robert Hale Bogden | Promoter | Pullman, WA |
| Colin Conrad Collins | Promoter | Vancouver, A1 |
| Keith David Miller | Promoter | Moscow, ID |
| ROBERT H BOGDEN | Director | PULLMAN, WA |
| ROBERT H BOGDEN | Executive Officer | PULLMAN, WA |
| ROBERT H BOGDEN | Promoter | PULLMAN, WA |
| KEITH H MILLER | Director | MOSCOW, ID |
| R. SCOTT H BLACKLEY | Director | LEESBURG, VT |
| COLIN H COLLINS | Director | VANCOUVER, A1 |
| STEPHEN H CRAWFORD | Director | BRONXVILLE, NY |
Other filings by this issuer (1)
More